UnitedHealth reported first-quarter 2026 adjusted earnings of $7.23 per share, surpassing the consensus estimate of $6.58, with revenues rising 2% year-over-year to $111.7 billion, beating expectations. The company improved its medical cost ratio and invested in technology and people, while UnitedHealthcare and Optum segments showed mixed revenue trends. UnitedHealth plans to acquire Alegeus Technologies and announced a $2 billion stock buyback. It raised its full-year 2026 adjusted earnings per share guidance to over $18.25, signaling confidence amid favorable Medicare Advantage payment increases for 2027. Shares rose over 7% in premarket trading following the news.
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
